Dai-ichi Life Insurance Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
3,455
+2,500
| +262% | +$815K | 0.03% | 343 |
|
|
2025
Q1 | $258K | Hold |
955
| – | – | 0.01% | 474 |
|
|
2024
Q4 | $225K | Hold |
955
| – | – | 0.01% | 476 |
|
|
2024
Q3 | $263K | Sell |
955
-122
| -11% | -$33.6K | 0.01% | 475 |
|
|
2024
Q2 | $262K | Buy |
+1,077
| New | +$262K | 0.01% | 437 |
|
|
2023
Q4 | – | Sell |
-7,100
| Closed | -$1.26M | – | 463 |
|
|
2023
Q3 | $1.26M | Buy |
7,100
+504
| +8% | +$89.3K | 0.03% | 344 |
|
|
2023
Q2 | $1.25M | Sell |
6,596
-383
| -5% | -$72.7K | 0.03% | 351 |
|
|
2023
Q1 | $1.4M | Hold |
6,979
| – | – | 0.03% | 337 |
|
|
2022
Q4 | $1.66M | Buy |
6,979
+4,040
| +137% | +$960K | 0.04% | 319 |
|
|
2022
Q3 | $588K | Hold |
2,939
| – | – | 0.01% | 419 |
|
|
2022
Q2 | $429K | Hold |
2,939
| – | – | 0.01% | 444 |
|
|
2022
Q1 | $480K | Hold |
2,939
| – | – | 0.01% | 460 |
|
|
2021
Q4 | $498K | Sell |
2,939
-418
| -12% | -$70.8K | 0.01% | 464 |
|
|
2021
Q3 | $634K | Hold |
3,357
| – | – | 0.01% | 457 |
|
|
2021
Q2 | $569K | Hold |
3,357
| – | – | 0.01% | 468 |
|
|
2021
Q1 | $474K | Hold |
3,357
| – | – | 0.01% | 470 |
|
|
2020
Q4 | $436K | Sell |
3,357
-3,918
| -54% | -$509K | 0.01% | 451 |
|
|
2020
Q3 | $1.06M | Hold |
7,275
| – | – | 0.02% | 381 |
|
|
2020
Q2 | $1.08M | Sell |
7,275
-261
| -3% | -$38.7K | 0.02% | 362 |
|
|
2020
Q1 | $820K | Hold |
7,536
| – | – | 0.03% | 383 |
|
|
2019
Q4 | $868K | Buy |
7,536
+214
| +3% | +$24.6K | 0.02% | 427 |
|
|
2019
Q3 | $589K | Hold |
7,322
| – | – | 0.01% | 449 |
|
|
2019
Q2 | $531K | Hold |
7,322
| – | – | 0.01% | 464 |
|
|
2019
Q1 | $684K | Buy |
+7,322
| New | +$684K | 0.02% | 438 |
|